Sanara MedTech Inc. (SMTI)
 NASDAQ: SMTI · Real-Time Price · USD
 29.03
 -0.27 (-0.92%)
  At close: Nov 3, 2025, 4:00 PM EST
28.99
 -0.04 (-0.14%)
  After-hours: Nov 3, 2025, 4:10 PM EST
Sanara MedTech Market Cap
Sanara MedTech has a market cap or net worth of $258.44 million as of November 3, 2025. Its market cap has decreased by -5.61% in one year.
Market Cap 
 258.44M
Enterprise Value 
 286.57M
1-Year Change 
 -5.61%
Ranking 
 Category 
 Stock Price 
$29.03
Market Cap Chart
Since December 1, 1998, Sanara MedTech's market cap has increased from $5.50M to $258.44M, an increase of 4,598.82%. That is a compound annual growth rate of 15.37%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 31, 2025 | 260.80M | -10.13% | 
| Dec 31, 2024 | 290.20M | -17.30% | 
| Dec 29, 2023 | 350.90M | -7.12% | 
| Dec 30, 2022 | 377.80M | 67.54% | 
| Dec 31, 2021 | 225.50M | -28.21% | 
| Dec 31, 2020 | 314.10M | 446.26% | 
| Dec 31, 2019 | 57.50M | 687.67% | 
| Dec 31, 2018 | 7.30M | 8.96% | 
| Dec 29, 2017 | 6.70M | 52.27% | 
| Dec 30, 2016 | 4.40M | -54.64% | 
| Dec 31, 2015 | 9.70M | 83.02% | 
| Dec 31, 2014 | 5.30M | -43.62% | 
| Dec 31, 2013 | 9.40M | 261.54% | 
| Dec 31, 2012 | 2.60M | -88.79% | 
| Dec 30, 2011 | 23.20M | 53.64% | 
| Dec 31, 2010 | 15.10M | -79.17% | 
| Dec 31, 2009 | 72.50M | -16.38% | 
| Dec 31, 2008 | 86.70M | 431.90% | 
| Dec 31, 2007 | 16.30M | 1,937.50% | 
| Dec 29, 2006 | 800.00K | -66.67% | 
| Dec 30, 2005 | 2.40M | -86.67% | 
| Dec 31, 2004 | 18.00M | 8,900.00% | 
| Dec 31, 2003 | 200.00K | - | 
| Dec 31, 2002 | - | -100.00% | 
| Dec 31, 2001 | 3.70M | -64.42% | 
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 772.59B | 
| Johnson & Johnson | 455.04B | 
| AbbVie | 385.18B | 
| UnitedHealth Group | 309.40B | 
| AstraZeneca | 253.98B | 
| Novartis AG | 237.13B | 
| Novo Nordisk | 216.87B | 
| Abbott Laboratories | 214.96B |